Overview

Mirabegron for Female OAB Patients: Comparison of Daytime and Nighttime Dosing

Status:
Recruiting
Trial end date:
2020-12-31
Target enrollment:
Participant gender:
Summary
The aim of this study is to elucidate whether night-time dosing of mirebegron can improve nocturia, compared with daytime dosing of mirabegron.
Phase:
Phase 4
Details
Lead Sponsor:
Far Eastern Memorial Hospital
Treatments:
Mirabegron